Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Gastric Cancer

Free Subscription Articles published in PLoS One Retrieve available abstracts of 197 articles: HTML format

Single Articles

January 2021
1. HUANG SC, Ng KF, Chang IY, Chang CJ, et al
   The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes.
   PLoS One. 2021;16:e0245356.
   PubMed     Abstract available
   
   
   
2. TOKUYAMA N, Takegawa N, Nishikawa M, Sakai A, et al
   Pretreatment Glasgow prognostic score as a predictor of outcomes in nivolumab-treated patients with advanced gastric cancer.
   PLoS One. 2021;16:e0247645.
   PubMed     Abstract available
   
   
   
3. KUMAMOTO T, Sasako M, Ishida Y, Kurahashi Y, et al
   Clinical outcomes of proximal gastrectomy for gastric cancer: A comparison between the double-flap technique and jejunal interposition.
   PLoS One. 2021;16:e0247636.
   PubMed     Abstract available
   
   
   
4. NODA H, Kaise M, Wada R, Koizumi E, et al
   Characteristics of non-neoplastic epithelium that appears within gastric cancer with and without Helicobacter pylori eradication: A retrospective study.
   PLoS One. 2021;16:e0248333.
   PubMed     Abstract available
   
   
   
5. MIN KW, Kim DH, Son BK, Moon KM, et al
   High SLC2A1 expression associated with suppressing CD8 T cells and B cells promoted cancer survival in gastric cancer.
   PLoS One. 2021;16:e0245075.
   PubMed     Abstract available
   
   
   January 2020
6. TOGANO S, Yashiro M, Miki Y, Yamamato Y, et al
   Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer.
   PLoS One. 2020;15:e0225958.
   PubMed     Abstract available
   
   
   
7. MORA-LAGOS B, Cartas-Espinel I, Riquelme I, Parker AC, et al
   Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines.
   PLoS One. 2020;15:e0228331.
   PubMed     Abstract available
   
   
   
8. MIFTAHUSSURUR M, Waskito LA, Aftab H, Vilaichone RK, et al
   Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.
   PLoS One. 2020;15:e0230064.
   PubMed     Abstract available
   
   
   
9. LEE JM, Park YM, Yun JS, Ahn YB, et al
   The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
   PLoS One. 2020;15:e0226351.
   PubMed     Abstract available
   
   
   
10. CALANDRINI DE AZEVEDO LF, Alves Ferreira TA, Melo KM, Porfirio Dias CL, et al
    Aqueous ethanol extract of Libidibia ferrea (Mart. Ex Tul) L.P. Queiroz (juca) exhibits antioxidant and migration-inhibiting activity in human gastric adenocarcinoma (ACP02) cells.
    PLoS One. 2020;15:e0226979.
    PubMed     Abstract available
    
    
    
11. PICCOLO G, Zanghi A, Di Vita M, Bisagni P, et al
    The role of E-cadherin expression in the treatment of western undifferentiated early gastric cancer: Can a biological factor predict lymph node metastasis?
    PLoS One. 2020;15:e0232429.
    PubMed     Abstract available
    
    
    
12. TOGANO S, Yashiro M, Miki Y, Yamamoto Y, et al
    Correction: Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer.
    PLoS One. 2020;15:e0233743.
    PubMed     Abstract available
    
    
    
13. DALHAMMAR K, Malmstrom M, Schelin M, Falkenback D, et al
    The impact of initial treatment strategy and survival time on quality of end-of-life care among patients with oesophageal and gastric cancer: A population-based cohort study.
    PLoS One. 2020;15:e0235045.
    PubMed     Abstract available
    
    
    
14. MORALES-ESPINOSA R, Delgado G, Serrano LR, Castillo E, et al
    High expression of Helicobacter pylori VapD in both the intracellular environment and biopsies from gastric patients with severity.
    PLoS One. 2020;15:e0230220.
    PubMed     Abstract available
    
    
    
15. TOKUHARA T, Nakata E, Tenjo T, Kawai I, et al
    Modified delta-shaped gastroduodenostomy consisting of linear stapling and single-layer suturing with the operator positioned between the patient's legs: A technique preventing intraoperative duodenal injury and postoperative anastomotic stenosis.
    PLoS One. 2020;15:e0230113.
    PubMed     Abstract available
    
    
    
16. ZHUNTOVA GV, Azizova TV, Grigoryeva ES
    Risk of stomach cancer incidence in a cohort of Mayak PA workers occupationally exposed to ionizing radiation.
    PLoS One. 2020;15:e0231531.
    PubMed     Abstract available
    
    
    
17. CHOI YJ, Ohn JH, Kim N, Kim W, et al
    Family-based exome sequencing combined with linkage analyses identifies rare susceptibility variants of MUC4 for gastric cancer.
    PLoS One. 2020;15:e0236197.
    PubMed     Abstract available
    
    
    
18. COTES SANCHIS A, Gallego J, Hernandez R, Arrazubi V, et al
    Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.
    PLoS One. 2020;15:e0235848.
    PubMed     Abstract available
    
    
    
19. KIM MR, Kim AS, Choi HI, Jung JH, et al
    Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0236445.
    PubMed     Abstract available
    
    
    
20. LI S, Peng L, Tan C, Zeng X, et al
    Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in China.
    PLoS One. 2020;15:e0232240.
    PubMed     Abstract available
    
    
    
21. JUNG J, Jeong S, Jeong H, Oh HE, et al
    Increased HOXC6 mRNA expression is a novel biomarker of gastric cancer.
    PLoS One. 2020;15:e0236811.
    PubMed     Abstract available
    
    
    
22. KOGURE A, Naito Y, Yamamoto Y, Yashiro M, et al
    Cancer cells with high-metastatic potential promote a glycolytic shift in activated fibroblasts.
    PLoS One. 2020;15:e0234613.
    PubMed     Abstract available
    
    
    
23. SANTOS-SANCHEZ V, Cordoba-Dona JA, Viciana F, Escolar-Pujolar A, et al
    Geographical variations in cancer mortality and social inequalities in southern Spain (Andalusia). 2002-2013.
    PLoS One. 2020;15:e0233397.
    PubMed     Abstract available
    
    
    
24. HERRERO R, Heise K, Acevedo J, Cook P, et al
    Regional variations in Helicobacter pylori infection, gastric atrophy and gastric cancer risk: The ENIGMA study in Chile.
    PLoS One. 2020;15:e0237515.
    PubMed     Abstract available
    
    
    
25. AUMPAN N, Vilaichone RK, Nunanan P, Chonprasertsuk S, et al
    Predictors for development of complete and incomplete intestinal metaplasia (IM) associated with H. pylori infection: A large-scale study from low prevalence area of gastric cancer (IM-HP trial).
    PLoS One. 2020;15:e0239434.
    PubMed     Abstract available
    
    
    
26. BANG S, Kim H, Jang K, Paik SS, et al
    The loss of nuclear expression of single-stranded DNA binding protein 2 of gastric adenocarcinoma and its prognostic role: Analysis of molecular subtype.
    PLoS One. 2020;15:e0236896.
    PubMed     Abstract available
    
    
    
27. SASAKI N, Iwaya T, Chiba T, Fujita M, et al
    Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA.
    PLoS One. 2020;15:e0239966.
    PubMed     Abstract available
    
    
    
28. HU Q, Masuda T, Kuramitsu S, Tobo T, et al
    Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
    PLoS One. 2020;15:e0241140.
    PubMed     Abstract available
    
    
    
29. ZHAO C, Feng Z, He H, Zang D, et al
    Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray.
    PLoS One. 2020;15:e0238836.
    PubMed     Abstract available
    
    
    
30. 
    Retraction: Decreased miR-204 in H. pylori-Associated Gastric Cancer Promotes Cancer Cell Proliferation and Invasion by Targeting SOX4.
    PLoS One. 2020;15:e0241451.
    PubMed    
    
    
    
31. SANIKINI H, Muller DC, Chadeau-Hyam M, Murphy N, et al
    Anthropometry, body fat composition and reproductive factors and risk of oesophageal and gastric cancer by subtype and subsite in the UK Biobank cohort.
    PLoS One. 2020;15:e0240413.
    PubMed     Abstract available
    
    
    
32. ZOU Q, Zhang H, Meng F, He L, et al
    Proteomic and transcriptomic studies of BGC823 cells stimulated with Helicobacter pylori isolates from gastric MALT lymphoma.
    PLoS One. 2020;15:e0238379.
    PubMed     Abstract available
    
    
    
33. KANG HJ, Lee HH, Jung SE, Park KS, et al
    Pattern of failure and optimal treatment strategy for primary gastric diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
    PLoS One. 2020;15:e0238807.
    PubMed     Abstract available
    
    
    
34. TSUMURA T, Kuroda S, Nishizaki M, Kikuchi S, et al
    Short-term and long-term comparisons of laparoscopy-assisted proximal gastrectomy with esophagogastrostomy by the double-flap technique and laparoscopy-assisted total gastrectomy for proximal gastric cancer.
    PLoS One. 2020;15:e0242223.
    PubMed     Abstract available
    
    
    
35. BU J, Lee TH, Jeong WJ, Poellmann MJ, et al
    Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer.
    PLoS One. 2020;15:e0242145.
    PubMed     Abstract available
    
    
    
36. 
    Retraction: Aberrant CCR4 Expression Is Involved in Tumor Invasion of Lymph Node-Negative Human Gastric Cancer.
    PLoS One. 2020;15:e0244287.
    PubMed    
    
    
    
37. ZHU SL, Dong J, Zhang C, Huang YB, et al
    Application of machine learning in the diagnosis of gastric cancer based on noninvasive characteristics.
    PLoS One. 2020;15:e0244869.
    PubMed     Abstract available
    
    
    
38. ALI AS, Langer SW, Federspiel B, Hjortland GO, et al
    PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3.
    PLoS One. 2020;15:e0243900.
    PubMed     Abstract available
    
    
    
39. TOYODA Y, Tabuchi T, Hama H, Morishima T, et al
    Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix.
    PLoS One. 2020;15:e0244644.
    PubMed     Abstract available
    
    
    January 2019
40. NAKAYAMA A, Abe H, Kunita A, Saito R, et al
    Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma.
    PLoS One. 2019;14:e0211358.
    PubMed     Abstract available
    
    
    
41. CHEN MW, Chan CP, Lin YJ, Yen HH, et al
    Anatomical location-based nodal staging system is superior to the 7th edition of the American Joint Committee on Cancer staging system among patients with surgically resected, histologically low-grade gastric cancer: A single institutional experience.
    PLoS One. 2019;14:e0211836.
    PubMed     Abstract available
    
    
    
42. YOON K, Kim N, Park Y, Kim BK, et al
    Correlation between macrophage migration inhibitory factor and autophagy in Helicobacter pylori-associated gastric carcinogenesis.
    PLoS One. 2019;14:e0211736.
    PubMed     Abstract available
    
    
    
43. YE S, Wang L, Zuo Z, Bei Y, et al
    The role of surgery and radiation in advanced gastric cancer: A population-based study of Surveillance, Epidemiology, and End Results database.
    PLoS One. 2019;14:e0213596.
    PubMed     Abstract available
    
    
    
44. HARADA H, Hosoda K, Moriya H, Mieno H, et al
    Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer.
    PLoS One. 2019;14:e0214872.
    PubMed     Abstract available
    
    
    
45. MIFTAHUSSURUR M, Waskito LA, Syam AF, Nusi IA, et al
    Analysis of risks of gastric cancer by gastric mucosa among Indonesian ethnic groups.
    PLoS One. 2019;14:e0216670.
    PubMed     Abstract available
    
    
    
46. MARTIN-ROMANO P, Solans BP, Cano D, Subtil JC, et al
    Neoadjuvant therapy for locally advanced gastric cancer patients. A population pharmacodynamic modeling.
    PLoS One. 2019;14:e0215970.
    PubMed     Abstract available
    
    
    
47. QIU HB, Zhang LY, Ren C, Zeng ZL, et al
    Correction: Targeting CDH17 Suppresses Tumor Progression in Gastric Cancer by Downregulating Wnt/beta-Catenin Signaling.
    PLoS One. 2019;14:e0217124.
    PubMed     Abstract available
    
    
    
48. WEI KL, Chou JL, Chen YC, Jin H, et al
    Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer.
    PLoS One. 2019;14:e0218338.
    PubMed     Abstract available
    
    
    
49. ZHANG L, Sun X, Si J, Li G, et al
    Umbelliprenin isolated from Ferula sinkiangensis inhibits tumor growth and migration through the disturbance of Wnt signaling pathway in gastric cancer.
    PLoS One. 2019;14:e0207169.
    PubMed     Abstract available
    
    
    
50. LEE JG, Kim SA, Eun CS, Han DS, et al
    Impact of age on stage-specific mortality in patients with gastric cancer: A long-term prospective cohort study.
    PLoS One. 2019;14:e0220660.
    PubMed     Abstract available
    
    
    
51. AKBARI M, Tabrizi R, Kardeh S, Lankarani KB, et al
    Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0219865.
    PubMed     Abstract available
    
    
    
52. EBERT K, Mattes J, Kunzke T, Zwingenberger G, et al
    MET as resistance factor for afatinib therapy and motility driver in gastric cancer cells.
    PLoS One. 2019;14:e0223225.
    PubMed     Abstract available
    
    
    
53. QIAN P, Li J, Zhang X, Li F, et al
    LMX1A inhibits C-Myc expression through ANGPTL4 to exert tumor suppressive role in gastric cancer.
    PLoS One. 2019;14:e0221640.
    PubMed     Abstract available
    
    
    
54. KOH JS, Joo MK, Park JJ, Lee BJ, et al
    Characteristics of proximal early gastric cancer differentiating distal early gastric cancer.
    PLoS One. 2019;14:e0223284.
    PubMed     Abstract available
    
    
    
55. WEI L, Chang J, Han Z, Wang R, et al
    Recombinant human growth hormone (rhGH) treatment of MKN-45 xenograft mice improves nutrition status and strengthens immune function without promoting tumor growth.
    PLoS One. 2019;14:e0210613.
    PubMed     Abstract available
    
    
    
56. RYU ES, Chang SJ, An J, Yang JY, et al
    Sex-specific differences in risk factors of lymph node metastasis in patients with early gastric cancer.
    PLoS One. 2019;14:e0224019.
    PubMed     Abstract available
    
    
    
57. KIM HJ, Kim SG, Kim J, Hong H, et al
    Clinical outcomes of early gastric cancer with non-curative resection after pathological evaluation based on the expanded criteria.
    PLoS One. 2019;14:e0224614.
    PubMed     Abstract available
    
    
    
58. LEE PC, Chiang JC, Chen CY, Chien YC, et al
    Calreticulin regulates vascular endothelial growth factor-A mRNA stability in gastric cancer cells.
    PLoS One. 2019;14:e0225107.
    PubMed     Abstract available
    
    
    
59. KURODA K, Yashiro M, Sera T, Yamamoto Y, et al
    The clinicopathological significance of Thrombospondin-4 expression in the tumor microenvironment of gastric cancer.
    PLoS One. 2019;14:e0224727.
    PubMed     Abstract available
    
    
    
60. 
    Retraction: Multidrug-Resistance Related Long Non-Coding RNA Expression Profile Analysis of Gastric Cancer.
    PLoS One. 2019;14:e0226210.
    PubMed    
    
    
    
61. YOON JY, Sy K, Brezden-Masley C, Streutker CJ, et al
    Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study.
    PLoS One. 2019;14:e0224812.
    PubMed     Abstract available
    
    
    
62. SHIN SY, Kim JH, Chun J, Yoon YH, et al
    Chronic atrophic gastritis and intestinal metaplasia surrounding diffuse-type gastric cancer: Are they just bystanders in the process of carcinogenesis?
    PLoS One. 2019;14:e0226427.
    PubMed     Abstract available
    
    
    
63. BODEN S, Myte R, Wennberg M, Harlid S, et al
    The inflammatory potential of diet in determining cancer risk; A prospective investigation of two dietary pattern scores.
    PLoS One. 2019;14:e0214551.
    PubMed     Abstract available
    
    
    
64. ZHANG X, Chen F, Yu T, An J, et al
    Real-time gastric polyp detection using convolutional neural networks.
    PLoS One. 2019;14:e0214133.
    PubMed     Abstract available
    
    
    
65. CHO JH, Kim JS, Kim ST, Hong JY, et al
    Selective colony area method for heterogeneous patient-derived tumor cell lines in anti-cancer drug screening system.
    PLoS One. 2019;14:e0215080.
    PubMed     Abstract available
    
    
    
66. LI P, Zhang X, Gu L, Zhou J, et al
    P16 methylation increases the sensitivity of cancer cells to the CDK4/6 inhibitor palbociclib.
    PLoS One. 2019;14:e0223084.
    PubMed     Abstract available
    
    
    
67. SEO AN, Jung Y, Jang H, Lee E, et al
    Clinical significance and prognostic role of hypoxia-induced microRNA 382 in gastric adenocarcinoma.
    PLoS One. 2019;14:e0223608.
    PubMed     Abstract available
    
    
    
68. KOCH C, Reitz C, Schreckenbach T, Eichler K, et al
    Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma.
    PLoS One. 2019;14:e0223613.
    PubMed     Abstract available
    
    
    
69. SOLIMAN C, Eastwood S, Truong VK, Ramsland PA, et al
    The membrane effects of melittin on gastric and colorectal cancer.
    PLoS One. 2019;14:e0224028.
    PubMed     Abstract available
    
    
    
70. KUROKAWA H, Ito H, Terasaki M, Matano D, et al
    Nitric oxide regulates the expression of heme carrier protein-1 via hypoxia inducible factor-1alpha stabilization.
    PLoS One. 2019;14:e0222074.
    PubMed     Abstract available
    
    
    
71. SUNG JY, Shin HT, Sohn KA, Shin SY, et al
    Assessment of intratumoral heterogeneity with mutations and gene expression profiles.
    PLoS One. 2019;14:e0219682.
    PubMed     Abstract available
    
    
    
72. CHOI S, Lee JG, Lee AR, Eun CS, et al
    Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance.
    PLoS One. 2019;14:e0225961.
    PubMed     Abstract available
    
    
    
73. ABRAHAM M, Kordatou Z, Barriuso J, Lamarca A, et al
    Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer.
    PLoS One. 2019;14:e0224540.
    PubMed     Abstract available
    
    
    
74. TAKAHASHI S, Shimizu S, Nagai S, Watanabe H, et al
    Characteristics of sarcopenia after distal gastrectomy in elderly patients.
    PLoS One. 2019;14:e0222412.
    PubMed     Abstract available
    
    
    January 2018
75. PEREZ-CASTILLO Y, Sanchez-Rodriguez A, Tejera E, Cruz-Monteagudo M, et al
    A desirability-based multi objective approach for the virtual screening discovery of broad-spectrum anti-gastric cancer agents.
    PLoS One. 2018;13:e0192176.
    PubMed     Abstract available
    
    
    
76. VAN DEN BOORN HG, Engelhardt EG, van Kleef J, Sprangers MAG, et al
    Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0192310.
    PubMed     Abstract available
    
    
    
77. YOON D, Bae K, Lee MK, Kim JH, et al
    Galanin is an epigenetically silenced tumor suppressor gene in gastric cancer cells.
    PLoS One. 2018;13:e0193275.
    PubMed     Abstract available
    
    
    
78. ARPALAHTI L, Laitinen A, Hagstrom J, Mustonen H, et al
    Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis.
    PLoS One. 2018;13:e0193125.
    PubMed     Abstract available
    
    
    
79. LI Z, Shan F, Wang Y, Zhang Y, et al
    Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis.
    PLoS One. 2018;13:e0189294.
    PubMed     Abstract available
    
    
    
80. KIM HY, Kim YH, Yun G, Chang W, et al
    Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer?
    PLoS One. 2018;13:e0194755.
    PubMed     Abstract available
    
    
    
81. XU X, Liu X, Zhang Y
    Osthole inhibits gastric cancer cell proliferation through regulation of PI3K/AKT.
    PLoS One. 2018;13:e0193449.
    PubMed     Abstract available
    
    
    
82. GONG EJ, Lee JY, Bae SE, Park YS, et al
    Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology.
    PLoS One. 2018;13:e0195264.
    PubMed     Abstract available
    
    
    
83. YOON HJ, Kim BS, Moon CM, Yoo J, et al
    Prognostic value of diffuse splenic FDG uptake on PET/CT in patients with gastric cancer.
    PLoS One. 2018;13:e0196110.
    PubMed     Abstract available
    
    
    
84. MA X, Wang B, Wang X, Luo Y, et al
    NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    PLoS One. 2018;13:e0192436.
    PubMed     Abstract available
    
    
    
85. 
    Correction: Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis.
    PLoS One. 2018;13:e0197013.
    PubMed     Abstract available
    
    
    
86. PARK SJ, Park YS, Jung IS, Yoon H, et al
    Is endoscopic surveillance necessary for patients who undergo total gastrectomy for gastric cancer?
    PLoS One. 2018;13:e0196170.
    PubMed     Abstract available
    
    
    
87. KAMOGAWA-SCHIFTER Y, Yamaoka Y, Uchida T, Beer A, et al
    Prevalence of Helicobacter pylori and its CagA subtypes in gastric cancer and duodenal ulcer at an Austrian tertiary referral center over 25 years.
    PLoS One. 2018;13:e0197695.
    PubMed     Abstract available
    
    
    
88. KOYAMA N, Katayanagi S, Kawachi S
    Pre-existing interstitial lung disease as a risk factor for pneumonitis associated with ramucirumab and paclitaxel in patients with gastric cancer: The impact of usual interstitial pneumonia.
    PLoS One. 2018;13:e0198886.
    PubMed     Abstract available
    
    
    
89. ZHANG F, Xu W, Liu J, Liu X, et al
    Optimizing miRNA-module diagnostic biomarkers of gastric carcinoma via integrated network analysis.
    PLoS One. 2018;13:e0198445.
    PubMed     Abstract available
    
    
    
90. CHOI IS, Choi M, Lee JH, Kim JH, et al
    Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study.
    PLoS One. 2018;13:e0198544.
    PubMed     Abstract available
    
    
    
91. KIM M, Pyo S, Kang CH, Lee CO, et al
    Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer.
    PLoS One. 2018;13:e0198347.
    PubMed     Abstract available
    
    
    
92. PENG J, Tan C, Zeng X, Liu S, et al
    Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer.
    PLoS One. 2018;13:e0199553.
    PubMed     Abstract available
    
    
    
93. BERARDI R, Torniai M, Partelli S, Rubini C, et al
    Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.
    PLoS One. 2018;13:e0197035.
    PubMed     Abstract available
    
    
    
94. PARK CJ, Seo N, Hyung WJ, Koom WS, et al
    Prognostic significance of preoperative CT findings in patients with advanced gastric cancer who underwent curative gastrectomy.
    PLoS One. 2018;13:e0202207.
    PubMed     Abstract available
    
    
    
95. LEE JS, Kim YS, Kim EY, Jin W, et al
    Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer.
    PLoS One. 2018;13:e0202700.
    PubMed     Abstract available
    
    
    
96. YAN S, Gan Y, Song X, Chen Y, et al
    Association between refrigerator use and the risk of gastric cancer: A systematic review and meta-analysis of observational studies.
    PLoS One. 2018;13:e0203120.
    PubMed     Abstract available
    
    
    
97. BIBI F, Ali I, Naseer MI, Ali Mohamoud HS, et al
    Detection of genetic alterations in gastric cancer patients from Saudi Arabia using comparative genomic hybridization (CGH).
    PLoS One. 2018;13:e0202576.
    PubMed     Abstract available
    
    
    
98. TALARICO S, Leverich CK, Wei B, Ma J, et al
    Increased H. pylori stool shedding and EPIYA-D cagA alleles are associated with gastric cancer in an East Asian hospital.
    PLoS One. 2018;13:e0202925.
    PubMed     Abstract available
    
    
    
99. JEONG O, Kim HG, Ryu SY, Park YK, et al
    Adverse prognostic impact of splenectomy on survival in gastric carcinoma patients: Regression and propensity score matching analysis of 1074 patients.
    PLoS One. 2018;13:e0203820.
    PubMed     Abstract available
    
    
    
100. MIKI Y, Yashiro M, Okuno T, Kuroda K, et al
     Clinico-pathological significance of exosome marker CD63 expression on cancer cells and stromal cells in gastric cancer.
     PLoS One. 2018;13:e0202956.
     PubMed     Abstract available
     
     
     
101. NIWA H, Ozawa R, Kurahashi Y, Kumamoto T, et al
     The eCura system as a novel indicator for the necessity of salvage surgery after non-curative ESD for gastric cancer: A case-control study.
     PLoS One. 2018;13:e0204039.
     PubMed     Abstract available
     
     
     
102. KAYAMBA V, Zyambo K, Kelly P
     Presence of blood in gastric juice: A sensitive marker for gastric cancer screening in a poor resource setting.
     PLoS One. 2018;13:e0205185.
     PubMed     Abstract available
     
     
     
103. MISUMI T, Tanabe K, Fujikuni N, Ohdan H, et al
     Stimulation of natural killer cells with rhCD137 ligand enhances tumor-targeting antibody efficacy in gastric cancer.
     PLoS One. 2018;13:e0204880.
     PubMed     Abstract available
     
     
     
104. NAM HS, Choi CW, Kim SJ, Kang DH, et al
     Preprocedural prediction of non-curative endoscopic submucosal dissection for early gastric cancer.
     PLoS One. 2018;13:e0206179.
     PubMed     Abstract available
     
     
     
105. CHOI IS, Kim JH, Lee JH, Suh KJ, et al
     A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study.
     PLoS One. 2018;13:e0205853.
     PubMed     Abstract available
     
     
     
106. LIU L, Song Z, Zhao Y, Li C, et al
     HAVCR1 expression might be a novel prognostic factor for gastric cancer.
     PLoS One. 2018;13:e0206423.
     PubMed     Abstract available
     
     
     
107. LIN XH, Huang KH, Chuang WH, Luo JC, et al
     The long term effect of metabolic profile and microbiota status in early gastric cancer patients after subtotal gastrectomy.
     PLoS One. 2018;13:e0206930.
     PubMed     Abstract available
     
     
     
108. KASURINEN A, Tervahartiala T, Laitinen A, Kokkola A, et al
     High serum MMP-14 predicts worse survival in gastric cancer.
     PLoS One. 2018;13:e0208800.
     PubMed     Abstract available
     
     
     
109. ZHAO X, Ren Y, Hu Y, Cui N, et al
     Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials.
     PLoS One. 2018;13:e0202185.
     PubMed     Abstract available
     
     
     
110. SHI Y, Li L, Xiao H, Guo S, et al
     Feasibility of laparoscopic gastrectomy for patients with Siewert-type II/III adenocarcinoma of the esophagogastric junction: A propensity score matching analysis.
     PLoS One. 2018;13:e0203125.
     PubMed     Abstract available
     
     
     
111. WANG VG, Kim H, Chuang JH
     Whole-exome sequencing capture kit biases yield false negative mutation calls in TCGA cohorts.
     PLoS One. 2018;13:e0204912.
     PubMed     Abstract available
     
     
     
112. WANG K, Duan X, Gao F, Wang W, et al
     Dissecting cancer heterogeneity based on dimension reduction of transcriptomic profiles using extreme learning machines.
     PLoS One. 2018;13:e0203824.
     PubMed     Abstract available
     
     
     January 2017
113. XIE G, Li W, Li R, Wu K, et al
     Helicobacter Pylori Promote B7-H1 Expression by Suppressing miR-152 and miR-200b in Gastric Cancer Cells.
     PLoS One. 2017;12:e0168822.
     PubMed     Abstract available
     
     
     
114. YANG L, Xu JF, Kang Q, Li AQ, et al
     Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage.
     PLoS One. 2017;12:e0169124.
     PubMed     Abstract available
     
     
     
115. YIN S, Huang J, Li Z, Zhang J, et al
     The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis.
     PLoS One. 2017;12:e0170042.
     PubMed     Abstract available
     
     
     
116. WEI X, Si N, Zhang Y, Zhao H, et al
     Evaluation of Bufadienolides as the Main Antitumor Components in Cinobufacin Injection for Liver and Gastric Cancer Therapy.
     PLoS One. 2017;12:e0169141.
     PubMed     Abstract available
     
     
     
117. SHAN X, Wen W, Zhu D, Yan T, et al
     miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
     PLoS One. 2017;12:e0170298.
     PubMed     Abstract available
     
     
     
118. EL KHADIR M, Alaoui Boukhris S, Benajah DA, El Rhazi K, et al
     VacA and CagA Status as Biomarker of Two Opposite End Outcomes of Helicobacter pylori Infection (Gastric Cancer and Duodenal Ulcer) in a Moroccan Population.
     PLoS One. 2017;12:e0170616.
     PubMed     Abstract available
     
     
     
119. GUO B, Wang W, Zhao Z, Li Q, et al
     Rab14 Act as Oncogene and Induce Proliferation of Gastric Cancer Cells via AKT Signaling Pathway.
     PLoS One. 2017;12:e0170620.
     PubMed     Abstract available
     
     
     
120. TSAI KF, Liou JM, Chen MJ, Chen CC, et al
     Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer.
     PLoS One. 2017;12:e0170942.
     PubMed     Abstract available
     
     
     
121. HUANG KS, Wang SH, Chuah SK, Rau KM, et al
     The effects of hospice-shared care for gastric cancer patients.
     PLoS One. 2017;12:e0171365.
     PubMed     Abstract available
     
     
     
122. ARORA N, Alsaied O, Dauer P, Majumder K, et al
     Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.
     PLoS One. 2017;12:e0171827.
     PubMed     Abstract available
     
     
     
123. CHAN DL, Sjoquist KM, Goldstein D, Price TJ, et al
     The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis.
     PLoS One. 2017;12:e0172307.
     PubMed     Abstract available
     
     
     
124. TERAWAKI K, Kashiwase Y, Sawada Y, Hashimoto H, et al
     Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model.
     PLoS One. 2017;12:e0173113.
     PubMed     Abstract available
     
     
     
125. HUA Z, Zheng X, Xue H, Wang J, et al
     Long-term trends and survival analysis of esophageal and gastric cancer in Yangzhong, 1991-2013.
     PLoS One. 2017;12:e0173896.
     PubMed     Abstract available
     
     
     
126. TAHARA T, Shibata T, Okubo M, Kawamura T, et al
     Evaluations of primary lesions by endoscopy clearly distinguishes prognosis in patients with gastric cancer who receive chemotherapy.
     PLoS One. 2017;12:e0173663.
     PubMed     Abstract available
     
     
     
127. VALAEE S, Yaghoobi MM, Shamsara M
     Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner.
     PLoS One. 2017;12:e0174486.
     PubMed     Abstract available
     
     
     
128. KOH J, Lee HE, Kim WH, Lee HS, et al
     Clinicopathologic implication of meticulous pathologic examination of regional lymph nodes in gastric cancer patients.
     PLoS One. 2017;12:e0174814.
     PubMed     Abstract available
     
     
     
129. LIU X, Chen S, Liu J, Xu D, et al
     Impact of systemic inflammation on gastric cancer outcomes.
     PLoS One. 2017;12:e0174085.
     PubMed     Abstract available
     
     
     
130. LU Y, Jing J, Sun L, Gong Y, et al
     Expression of claudin-11, -23 in different gastric tissues and its relationship with the risk and prognosis of gastric cancer.
     PLoS One. 2017;12:e0174476.
     PubMed     Abstract available
     
     
     
131. CHEN XD, Mao CC, Wu RS, Zhang WT, et al
     Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer.
     PLoS One. 2017;12:e0175074.
     PubMed     Abstract available
     
     
     
132. GALIZIA G, Lieto E, Auricchio A, Cardella F, et al
     Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience.
     PLoS One. 2017;12:e0173619.
     PubMed     Abstract available
     
     
     
133. DAI M, Yuan F, Fu C, Shen G, et al
     Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
     PLoS One. 2017;12:e0175357.
     PubMed     Abstract available
     
     
     
134. JIA S, Qu T, Wang X, Feng M, et al
     KIAA1199 promotes migration and invasion by Wnt/beta-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.
     PLoS One. 2017;12:e0175058.
     PubMed     Abstract available
     
     
     
135. COMPANIONI O, Sanz-Anquela JM, Pardo ML, Puigdecanet E, et al
     Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.
     PLoS One. 2017;12:e0176043.
     PubMed     Abstract available
     
     
     
136. MA J, Wu D, Hu X, Li J, et al
     Associations between cytokine gene polymorphisms and susceptibility to Helicobacter pylori infection and Helicobacter pylori related gastric cancer, peptic ulcer disease: A meta-analysis.
     PLoS One. 2017;12:e0176463.
     PubMed     Abstract available
     
     
     
137. ARMERO VES, Tremblay MP, Allaire A, Boudreault S, et al
     Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas.
     PLoS One. 2017;12:e0176880.
     PubMed     Abstract available
     
     
     
138. LIN XL, Xu Q, Tang L, Sun L, et al
     Regorafenib inhibited gastric cancer cells growth and invasion via CXCR4 activated Wnt pathway.
     PLoS One. 2017;12:e0177335.
     PubMed     Abstract available
     
     
     
139. HUNG PS, Chen CY, Chen WT, Kuo CY, et al
     miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma.
     PLoS One. 2017;12:e0177346.
     PubMed     Abstract available
     
     
     
140. CHOI JM, Kim SG, Kim J, Han SJ, et al
     Clinical implications of pre-existing adenoma in endoscopically resected early gastric cancers.
     PLoS One. 2017;12:e0178419.
     PubMed     Abstract available
     
     
     
141. KASASHIMA H, Yashiro M, Nakamae H, Masuda G, et al
     Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma.
     PLoS One. 2017;12:e0178635.
     PubMed     Abstract available
     
     
     
142. LI F, Guo Y, Liu J, Zhang R, et al
     The significance of elevated plasma expression of microRNA 106b~25 clusters in gastric cancer.
     PLoS One. 2017;12:e0178427.
     PubMed     Abstract available
     
     
     
143. KANG HM, Kim GH, Jeon HK, Kim DH, et al
     Circulating tumor cells detected by lab-on-a-disc: Role in early diagnosis of gastric cancer.
     PLoS One. 2017;12:e0180251.
     PubMed     Abstract available
     
     
     
144. LI SC, Lee CH, Hung CL, Wu JC, et al
     Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: A population-based study.
     PLoS One. 2017;12:e0182255.
     PubMed     Abstract available
     
     
     
145. CHENG S, Mao Q, Dong Y, Ren J, et al
     GNB2L1 and its O-GlcNAcylation regulates metastasis via modulating epithelial-mesenchymal transition in the chemoresistance of gastric cancer.
     PLoS One. 2017;12:e0182696.
     PubMed     Abstract available
     
     
     
146. GU L, Chen M, Guo D, Zhu H, et al
     PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.
     PLoS One. 2017;12:e0182692.
     PubMed     Abstract available
     
     
     
147. CAI J, Wang D, Bai ZG, Yin J, et al
     The long noncoding RNA XIAP-AS1 promotes XIAP transcription by XIAP-AS1 interacting with Sp1 in gastric cancer cells.
     PLoS One. 2017;12:e0182433.
     PubMed     Abstract available
     
     
     
148. NA HK, Cho CJ, Bae SE, Lee JH, et al
     Atrophic and Metaplastic Progression in the Background Mucosa of Patients with Gastric Adenoma.
     PLoS One. 2017;12:e0169456.
     PubMed     Abstract available
     
     
     
149. SETA T, Takahashi Y, Noguchi Y, Shikata S, et al
     Effectiveness of Helicobacter pylori eradication in the prevention of primary gastric cancer in healthy asymptomatic people: A systematic review and meta-analysis comparing risk ratio with risk difference.
     PLoS One. 2017;12:e0183321.
     PubMed     Abstract available
     
     
     
150. SHA J, Wang P, Zhu B, Zhu M, et al
     Acetic Acid Enhanced Narrow Band Imaging for the Diagnosis of Gastric Intestinal Metaplasia.
     PLoS One. 2017;12:e0170957.
     PubMed     Abstract available
     
     
     
151. LAITINEN A, Bockelman C, Hagstrom J, Kokkola A, et al
     High PROX1 expression in gastric cancer predicts better survival.
     PLoS One. 2017;12:e0183868.
     PubMed     Abstract available
     
     
     
152. HAN W, Zhang Z, He B, Xu Y, et al
     Integrated analysis of long non-coding RNAs in human gastric cancer: An in silico study.
     PLoS One. 2017;12:e0183517.
     PubMed     Abstract available
     
     
     
153. MITSUISHI T, Hamatani S, Hirooka S, Fukasawa N, et al
     Clinicopathological characteristics of duodenal epithelial neoplasms: Focus on tumors with a gastric mucin phenotype (pyloric gland-type tumors).
     PLoS One. 2017;12:e0174985.
     PubMed     Abstract available
     
     
     
154. KIM KH, Yeo SG, Yoo BC, Myung JK, et al
     Identification of calgranulin B interacting proteins and network analysis in gastrointestinal cancer cells.
     PLoS One. 2017;12:e0171232.
     PubMed     Abstract available
     
     
     
155. SCHUMACHER SE, Shim BY, Corso G, Ryu MH, et al
     Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients.
     PLoS One. 2017;12:e0176045.
     PubMed     Abstract available
     
     
     
156. VANGE P, Bruland T, Doseth B, Fossmark R, et al
     The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival.
     PLoS One. 2017;12:e0184514.
     PubMed     Abstract available
     
     
     
157. PATTISON S, Mitchell C, Lade S, Leong T, et al
     Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer.
     PLoS One. 2017;12:e0183891.
     PubMed     Abstract available
     
     
     
158. PARK JY, Kim SG, Kim J, Han SJ, et al
     Risk factors for early metachronous tumor development after endoscopic resection for early gastric cancer.
     PLoS One. 2017;12:e0185501.
     PubMed     Abstract available
     
     
     
159. ELLISON-LOSCHMANN L, Sporle A, Corbin M, Cheng S, et al
     Risk of stomach cancer in Aotearoa/New Zealand: A Maori population based case-control study.
     PLoS One. 2017;12:e0181581.
     PubMed     Abstract available
     
     
     
160. HUERTA JM, Chirlaque MD, Molina AJ, Amiano P, et al
     Physical activity domains and risk of gastric adenocarcinoma in the MCC-Spain case-control study.
     PLoS One. 2017;12:e0179731.
     PubMed     Abstract available
     
     
     
161. AFTAB H, Miftahussurur M, Subsomwong P, Ahmed F, et al
     Two populations of less-virulent Helicobacter pylori genotypes in Bangladesh.
     PLoS One. 2017;12:e0182947.
     PubMed     Abstract available
     
     
     
162. CHO JH, Lim JY, Cho JY
     Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy.
     PLoS One. 2017;12:e0186362.
     PubMed     Abstract available
     
     
     
163. CHOI YJ, Lee DH, Han KD, Kim HS, et al
     The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.
     PLoS One. 2017;12:e0185778.
     PubMed     Abstract available
     
     
     
164. ZHANG X, Hu W, Chen F, Liu J, et al
     Gastric precancerous diseases classification using CNN with a concise model.
     PLoS One. 2017;12:e0185508.
     PubMed     Abstract available
     
     
     
165. KAYAMBA V, Shibemba A, Zyambo K, Heimburger DC, et al
     High prevalence of gastric intestinal metaplasia detected by confocal laser endomicroscopy in Zambian adults.
     PLoS One. 2017;12:e0184272.
     PubMed     Abstract available
     
     
     
166. HUANG JY, Wang R, Gao YT, Yuan JM, et al
     ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.
     PLoS One. 2017;12:e0184295.
     PubMed     Abstract available
     
     
     
167. FORNARO L, Vivaldi C, Lin D, Xue H, et al
     Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation.
     PLoS One. 2017;12:e0182818.
     PubMed     Abstract available
     
     
     
168. SUBSOMWONG P, Miftahussurur M, Uchida T, Vilaichone RK, et al
     Prevalence, risk factors, and virulence genes of Helicobacter pylori among dyspeptic patients in two different gastric cancer risk regions of Thailand.
     PLoS One. 2017;12:e0187113.
     PubMed     Abstract available
     
     
     
169. FISCHER C, Lingsma H, Klazinga N, Hardwick R, et al
     Volume-outcome revisited: The effect of hospital and surgeon volumes on multiple outcome measures in oesophago-gastric cancer surgery.
     PLoS One. 2017;12:e0183955.
     PubMed     Abstract available
     
     
     
170. WANG SH, Wang KL, Yang WK, Lee TH, et al
     Expression and potential roles of sodium-potassium ATPase and E-cadherin in human gastric adenocarcinoma.
     PLoS One. 2017;12:e0183692.
     PubMed     Abstract available
     
     
     
171. FANG WL, Huang KH, Chen MH, Liu CA, et al
     Comparative study of the 7th and 8th AJCC editions for gastric cancer patients after curative surgery.
     PLoS One. 2017;12:e0187626.
     PubMed     Abstract available
     
     
     
172. GUAN H, Li W, Li Y, Wang J, et al
     MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2.
     PLoS One. 2017;12:e0189490.
     PubMed     Abstract available
     
     
     
173. CHOI YY, Noh SH, An JY
     A randomized controlled trial of Roux-en-Y gastrojejunostomy vs. gastroduodenostomy with respect to the improvement of type 2 diabetes mellitus after distal gastrectomy in gastric cancer patients.
     PLoS One. 2017;12:e0188904.
     PubMed     Abstract available
     
     
     
174. ZHI P, Shi J, Liu F
     Genetic variations at 8q24 and gastric cancer susceptibility: A meta-analysis study.
     PLoS One. 2017;12:e0188774.
     PubMed     Abstract available
     
     
     
175. JEONG A, An JY
     The moderating role of social support on depression and anxiety for gastric cancer patients and their family caregivers.
     PLoS One. 2017;12:e0189808.
     PubMed     Abstract available
     
     
     
176. UM YJ, Kim HW, Jung DH, Kim JH, et al
     The longest diameter of tumor as a parameter of endoscopic resection in early gastric cancer: In comparison with tumor area.
     PLoS One. 2017;12:e0189649.
     PubMed     Abstract available
     
     
     January 2016
177. HU GY, Tao F, Ji KW, Wang W, et al
     Comparison of Delta-Shape Anastomosis and Extracorporeal Billroth I Anastomosis after Laparoscopic Distal Gastrectomy for Gastric Cancer: A Systematic Review with Meta-Analysis of Short-Term Outcomes.
     PLoS One. 2016;11:e0162720.
     PubMed     Abstract available
     
     
     
178. RAMACHANDRAN GK, Yong WP, Yeow CH
     Identification of Gastric Cancer Biomarkers Using 1H Nuclear Magnetic Resonance Spectrometry.
     PLoS One. 2016;11:e0162222.
     PubMed     Abstract available
     
     
     
179. XU Z, Xu W, Cheng H, Shen W, et al
     The Prognostic Role of the Platelet-Lymphocytes Ratio in Gastric Cancer: A Meta-Analysis.
     PLoS One. 2016;11:e0163719.
     PubMed     Abstract available
     
     
     
180. ZHU W, Ye L, Zhang J, Yu P, et al
     PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer.
     PLoS One. 2016;11:e0163768.
     PubMed     Abstract available
     
     
     
181. TAHARA T, Shibata T, Horiguchi N, Kawamura T, et al
     A Possible Link between Gastric Mucosal Atrophy and Gastric Cancer after Helicobacter pylori Eradication.
     PLoS One. 2016;11:e0163700.
     PubMed     Abstract available
     
     
     
182. LEE YJ, Kim JH, Park JJ, Youn YH, et al
     The Implications of Endoscopic Ulcer in Early Gastric Cancer: Can We Predict Clinical Behaviors from Endoscopy?
     PLoS One. 2016;11:e0164339.
     PubMed     Abstract available
     
     
     
183. QI J, Zhang P, Wang Y, Chen H, et al
     Does Total Gastrectomy Provide Better Outcomes than Distal Subtotal Gastrectomy for Distal Gastric Cancer? A Systematic Review and Meta-Analysis.
     PLoS One. 2016;11:e0165179.
     PubMed     Abstract available
     
     
     
184. LAI HT, Koriyama C, Tokudome S, Tran HH, et al
     Waterpipe Tobacco Smoking and Gastric Cancer Risk among Vietnamese Men.
     PLoS One. 2016;11:e0165587.
     PubMed     Abstract available
     
     
     
185. GOSSMANN J, Stolte M, Lohoff M, Yu P, et al
     A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma.
     PLoS One. 2016;11:e0150411.
     PubMed     Abstract available
     
     
     
186. DING Y, Yang Q, Wang B, Ye G, et al
     The Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-Analysis.
     PLoS One. 2016;11:e0165509.
     PubMed     Abstract available
     
     
     
187. WANG J, Fei X, Wu W, Chen X, et al
     SLC7A5 Functions as a Downstream Target Modulated by CRKL in Metastasis Process of Gastric Cancer SGC-7901 Cells.
     PLoS One. 2016;11:e0166147.
     PubMed     Abstract available
     
     
     
188. KIM CS, Bae EH, Ma SK, Kweon SS, et al
     Impact of Transient and Persistent Acute Kidney Injury on Chronic Kidney Disease Progression and Mortality after Gastric Surgery for Gastric Cancer.
     PLoS One. 2016;11:e0168119.
     PubMed     Abstract available
     
     
     
189. WANG X, Wei Y, Xue Y, Lu P, et al
     Predictive Role of the Number of 18F-FDG-Positive Lymph Nodes Detected by PET/CT for Pre-Treatment Evaluation of Locally Advanced Gastric Cancer.
     PLoS One. 2016;11:e0166836.
     PubMed     Abstract available
     
     
     
190. LI J, Wang Y, Li QG, Xue JJ, et al
     Downregulation of FBP1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Gastric Cancer via Regulating Epithelial-Mesenchymal Transition.
     PLoS One. 2016;11:e0167857.
     PubMed     Abstract available
     
     
     
191. PARK HJ, Ahn JY, Jung HY, Lee JH, et al
     Clinical Characteristics and Outcomes of Gastric Cancer Patients Aged over 80 Years: A Retrospective Case-Control Study.
     PLoS One. 2016;11:e0167615.
     PubMed     Abstract available
     
     
     
192. CAO GD, Xu XY, Zhang JW, Chen B, et al
     Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
     PLoS One. 2016;11:e0168085.
     PubMed     Abstract available
     
     
     
193. WANG H, Zheng Y, Lai J, Luo Q, et al
     Methylation-Sensitive Melt Curve Analysis of the Reprimo Gene Methylation in Gastric Cancer.
     PLoS One. 2016;11:e0168635.
     PubMed     Abstract available
     
     
     
194. WANG B, Chen Q, Cao Y, Ma X, et al
     LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
     PLoS One. 2016;11:e0168904.
     PubMed     Abstract available
     
     
     
195. LOPE V, Fernandez de Larrea N, Perez-Gomez B, Martin V, et al
     Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain.
     PLoS One. 2016;11:e0164620.
     PubMed     Abstract available
     
     
     
196. KUNISAWA S, Fushimi K, Imanaka Y
     Reducing Length of Hospital Stay Does Not Increase Readmission Rates in Early-Stage Gastric, Colon, and Lung Cancer Surgical Cases in Japanese Acute Care Hospitals.
     PLoS One. 2016;11:e0166269.
     PubMed     Abstract available
     
     
     
197. MASOOMPOUR SM, Lankarani KB, Honarvar B, Tabatabaee SH, et al
     Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study.
     PLoS One. 2016;11:e0155669.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: